Pular para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Título
Autor
Assunto
Número de Chamada
ISBN/ISSN
Tag
Buscar
Avançada
Selective Inhibition of AKT Pr...
Citar
Enviar por SMS
Enviar por e-mail
Imprimir
Exportar registro
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Link permanente
Selective Inhibition of AKT Protein Isoforms Augments Gefitinib Response in EGFR Mutated NSCLC Cells
Detalhes bibliográficos
Principais autores:
Bokobza, S
,
Devery, A
,
Weber, A
,
Jiang, Y
,
Ryan, A
Formato:
Conference item
Publicado em:
2012
Itens
Descrição
Registros relacionados
Registro fonte
Registros relacionados
First-line treatment with gefitinib in combination with bevacizumab and chemotherapy in advanced non-squamous NSCLC with EGFR-mutation
por: Yanjuan Xiong, et al.
Publicado em: (2024-10-01)
Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer
por: Weber, A, et al.
Publicado em: (2016)
Gefitinib and EGFR gene copy number aberrations in esophageal cancer
por: Petty, RD, et al.
Publicado em: (2017)
Mutational analysis of isoform selectivity and conformational equilibria in protein kinase inhibition
por: Alexander, LT
Publicado em: (2015)
β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy
por: Ruonan Zhang, et al.
Publicado em: (2024-05-01)